Annual CFF
$68.13 M
+$24.34 M+55.59%
31 December 2023
Summary:
Alto Neuroscience annual cash flow from financing activities is currently $68.13 million, with the most recent change of +$24.34 million (+55.59%) on 31 December 2023. ANRO annual CFF is now at all-time high.ANRO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$1.32 M
+$1.55 M+662.82%
30 September 2024
Summary:
Alto Neuroscience quarterly cash flow from financing activities is currently $1.32 million, with the most recent change of +$1.55 million (+662.82%) on 30 September 2024. Over the past year, it has increased by +$1.27 million (+2587.76%). ANRO quarterly CFF is now -99.02% below its all-time high of $134.56 million, reached on 31 March 2024.ANRO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$178.77 M
+$1.27 M+0.71%
30 September 2024
Summary:
Alto Neuroscience TTM cash flow from financing activities is currently $178.77 million, with the most recent change of +$1.27 million (+0.71%) on 30 September 2024. Over the past year, it has increased by +$153.78 million (+615.15%). ANRO TTM CFF is now at all-time high.ANRO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANRO Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.6% | +2587.8% | +615.1% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ANRO Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +115.0% | -99.0% | +662.8% | at high | +616.6% |
| 5 y | 5 years | at high | +115.0% | -99.0% | +662.8% | at high | +616.6% |
| alltime | all time | at high | +115.0% | -99.0% | +662.8% | at high | +616.6% |
Alto Neuroscience Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.32 M(-662.8%) | $178.77 M(+0.7%) |
| June 2024 | - | -$234.00 K(-100.2%) | $177.51 M(-0.1%) |
| Mar 2024 | - | $134.56 M(+212.0%) | $177.69 M(+160.8%) |
| Dec 2023 | $68.13 M | $43.13 M(>+9900.0%) | $68.13 M(+172.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $49.00 K(-196.1%) | $25.00 M(+0.2%) |
| June 2023 | - | -$51.00 K(-100.2%) | $24.95 M(-0.2%) |
| Mar 2023 | - | $25.00 M | $25.00 M |
| Dec 2022 | $43.79 M(+38.2%) | - | - |
| Dec 2021 | $31.69 M | - | - |
FAQ
- What is Alto Neuroscience annual cash flow from financing activities?
- What is the all time high annual CFF for Alto Neuroscience?
- What is Alto Neuroscience annual CFF year-on-year change?
- What is Alto Neuroscience quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Alto Neuroscience?
- What is Alto Neuroscience quarterly CFF year-on-year change?
- What is Alto Neuroscience TTM cash flow from financing activities?
- What is the all time high TTM CFF for Alto Neuroscience?
- What is Alto Neuroscience TTM CFF year-on-year change?
What is Alto Neuroscience annual cash flow from financing activities?
The current annual CFF of ANRO is $68.13 M
What is the all time high annual CFF for Alto Neuroscience?
Alto Neuroscience all-time high annual cash flow from financing activities is $68.13 M
What is Alto Neuroscience annual CFF year-on-year change?
Over the past year, ANRO annual cash flow from financing activities has changed by +$24.34 M (+55.59%)
What is Alto Neuroscience quarterly cash flow from financing activities?
The current quarterly CFF of ANRO is $1.32 M
What is the all time high quarterly CFF for Alto Neuroscience?
Alto Neuroscience all-time high quarterly cash flow from financing activities is $134.56 M
What is Alto Neuroscience quarterly CFF year-on-year change?
Over the past year, ANRO quarterly cash flow from financing activities has changed by +$1.27 M (+2587.76%)
What is Alto Neuroscience TTM cash flow from financing activities?
The current TTM CFF of ANRO is $178.77 M
What is the all time high TTM CFF for Alto Neuroscience?
Alto Neuroscience all-time high TTM cash flow from financing activities is $178.77 M
What is Alto Neuroscience TTM CFF year-on-year change?
Over the past year, ANRO TTM cash flow from financing activities has changed by +$153.78 M (+615.15%)